Hikma Pharmaceutical reported $173M in Net Income for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Artemis Alpha ATS:LN GBP -26769000 16.52M
AstraZeneca AZN:LN USD 1.64B 1.28B
Bayer BAYN:GR EUR 546M 844M
Fresenius FRE:GR EUR 322M 61M
Fresenius Medical Care FMS:US EUR 230.1M 82.96M
Galapagos GLPG:NA EUR 21.55M 40.58M
Genmab GEN:DC DKK 2.58B 691M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Hikma Pharmaceutical HIK:LN USD 173M 0
Lonza Group LONN:SW CHF 492M 2.13B
Merck MRK:GR EUR 923M 56M
Orion ORNBV:FH EUR 194.5M 128.4M
Recordati REC:IM EUR 90.05M 35.37M